Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia

Leuk Lymphoma. 2016;57(4):965-8. doi: 10.3109/10428194.2015.1085530. Epub 2015 Dec 23.

Authors

Jacopo Olivieri¹, Giorgia Mancini², Gaia Goteri³, Ilaria Scortechini², Federica Giantomassi³, Martina Chiarucci¹, Pietro Leoni¹, Attilio Olivieri¹

Affiliations

¹ a Clinica di Ematologia, Università Politecnica Delle Marche , Ancona , Italy ;
² b Clinica di Ematologia, Azienda Ospedaliera-Universitaria "Ospedali Riuniti" , Ancona , Italy ;
³ c Anatomia Patologica, Università Politecnica Delle Marche , Ancona , Italy.

PMID: 26402469
DOI: 10.3109/10428194.2015.1085530

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia, Aplastic / diagnosis
Anemia, Aplastic / therapy*
Female
Graft Survival / drug effects*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Iron Chelating Agents / pharmacology
Iron Chelating Agents / therapeutic use*
Severity of Illness Index
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome

Substances

Iron Chelating Agents